p38 MAPK Molecular Targeting for Next-Generation Multiple Myeloma Therapy

Abstract excerpt

Resistance to therapy and disease progression are the main causes of mortality in most cancers. In particular, the development of resistance is an important limitation affecting the efficacy of therapeutic alternatives for cancer, including chemotherapy, radiotherapy, and immunotherapy. Signaling pathways are largely responsible for the mechanisms of resistance to cancer treatment and progression, and multiple mye...

Topics

Open a Topic to create a Post that cites this publication.

• Drug Discovery
• Extracellular Signal-Regulated MAP Kinases
• MAP Kinase Signaling System
• Melanoma and MAPK Pathways
• Molecular Targeted Therapy
• Multiple Myeloma
• Multiple Myeloma Research and Treatments
• Oncogene Protein v-akt

Identifiers and source

Literature Corpus work

3b78e486-2360-5940-9154-726faa3ad458

DOI

10.20944/preprints202401.0262.v1